|
|
Volumn 6, Issue 6, 2010, Pages 993-1002
|
|
Recently identified and potential targets for colon cancer treatment.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTIOXIDANT;
FLAVONOID;
HISTONE DEACETYLASE INHIBITOR;
MICRORNA;
OXIDIZING AGENT;
PHENOL DERIVATIVE;
POLYPHENOLS;
PROTEIN KINASE INHIBITOR;
RNA;
TUMOR PROTEIN;
ADENOCARCINOMA;
ANIMAL;
COLON TUMOR;
COLORECTAL TUMOR;
DISEASE COURSE;
DRUG ANTAGONISM;
DRUG DELIVERY SYSTEM;
DRUG DEVELOPMENT;
DRUG EFFECT;
DRUG SCREENING;
GENE EXPRESSION REGULATION;
GENETIC EPIGENESIS;
GENETICS;
GLYCOLYSIS;
HUMAN;
MOUSE;
PERSONALIZED MEDICINE;
REVIEW;
ADENOCARCINOMA;
ANIMALS;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
ANTIOXIDANTS;
COLONIC NEOPLASMS;
COLORECTAL NEOPLASMS;
DISEASE PROGRESSION;
DRUG DELIVERY SYSTEMS;
DRUG DISCOVERY;
EPIGENESIS, GENETIC;
FLAVONOIDS;
GENE EXPRESSION REGULATION, NEOPLASTIC;
GLYCOLYSIS;
HISTONE DEACETYLASE INHIBITORS;
HUMANS;
INDIVIDUALIZED MEDICINE;
MICE;
MICRORNAS;
NEOPLASM PROTEINS;
OXIDANTS;
PHENOLS;
PROTEIN KINASE INHIBITORS;
RNA, NEOPLASM;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
MLCS;
MLOWN;
|
|
EID: 77957279353
PISSN: None
EISSN: 17448301
Source Type: Journal
DOI: 10.2217/fon.10.53 Document Type: Review |
|
Times cited : (22)
|
|
References (73)
|
